| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Spero Therapeutics, Inc. | Chief Operating Officer | Common Stock | 63,581 | $80,748 | $1.27 | 01 Feb 2022 | Direct |
| Spero Therapeutics, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 53,190 | $59,573 | $1.12 | 01 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SPRO | Spero Therapeutics, Inc. | 01 Feb 2022 | 2 | $0 | 4 | Chief Operating Officer | 03 Feb 2022, 15:18 |
| SPRO | Spero Therapeutics, Inc. | 26 Aug 2021 | 1 | $0 | 4 | Chief Operating Officer | 30 Aug 2021, 16:15 |